Regenerative Medicine Market

Regenerative Medicine Market: Increased in bone and joint surgeries and increased prevalence of neurodegenerative, orthopedic, oncology, and genetic diseases are the key drivers for Global Regenerative Medicine Market.

Regenerative Medicine Market is valued at around USD 12.34 Billion in 2017 and expected to reach USD 44.63 Billion by 2024 with the CAGR of 20.16% over the forecast period.

Regenerative Medicine market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about regenerative medicine market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with of Product Type, application, therapy.

Regenerative medicines are those medicines which are used to repair, regenerate, and replace the tissues or organs damaged due to disease, injury or natural aging. Regenerative medicines are used in the treatment of various disorders such as orthopedic, neurodegenerative, oncology and others. These medicines help in the restoration of natural functioning of the organs and tissues. Regenerative medicines can also be used for the treatment of various chronic and genetic disorders, it also helps in the treatment of organ transplant which has reduced the rejection cases to a major extent.

There are various factors driving the growth of the regenerative medicine market, one of the major driving the growth of the market are increased prevalence of various chronic and genetic diseases over the period of time. Moreover, increase in technological advancement has also help in the development of effective and better therapies for the treatment of chronic disorders. Furthermore, the increased burden of these diseases has increased the demand of various effective medications which led to the increase in the regenerative medicine market. Increased research on stem cells has given a new direction to the regenerative medicines an expected to create various opportunities over the forecast period. However, high cost of treatment and stringent government regulations are expected to inhibit the growth of regenerative medicines over the forecast period.

Regenerative Medicine Market Segmentation

By Product Type - Cell-based products, Acellular products

By Application - Orthopedic & Musculoskeletal Disorders, Cardiology, Dermatology, Diabetes, Central Nervous System Disorders, Others

By Therapy - Cell therapy, Gene therapy, Tissue engineering, Immunotherapy

By Region

North America
• U.S.
• Canada

Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific
• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America
• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Regenerative Medicine Market Key Players

• Stryker Corporation
• Cook Biotech Inc.
• Vericel Corporation
• DePuy Synthes Inc.
• Medtronic Inc.
• Organogenesis Inc.
• Osiris Therapeutics Inc.
• NuVasive Inc.
• Zimmer Holdings Inc.
• Integra LifeSciences
• Bristol-Myers Squibb Company (U.S.)
• Tissue Regenix (U.K.)
• Smith & Nephew (U.K.)
• MIMEDX (U.S.)
• Novartis AG (Switzerland)
• Allergan Aesthetics (AbbVie Inc.)
• American CryoStem Corporation
• Kite (Gilead Science)
• Others.